| G ENER ATI ON OF G ENE TI C ALLY MOD IFIED PI G S IN CHINA

| The history
Tracing the history of genetically modified pigs in China,an embryologist named Dizhou Tong ( Figure 1A ), called "Father of cloning in China," was the first scientist to perform somatic cloning between Asian and European carp. 5, 6 In 1963, 34 years before the cloned During the next year, Dr Zhonghua Liu from Northwest University produced the first Green Fluorescent Protein (GFP) transgenic pig by transgenic somatic cell nuclear transfer (SCNT, Figure 2B ). 8 This was the fourth GFP transgenic pig in the world following those of the United States, South Korea, and Japan. In 2011, Dr Dengke Pan and his research team successfully generated a genetically modified α-galactosyltransferase knockout (GTKO) pig ( Figure 2C ). 9 This paved the way for pig-to-human xenotransplantation as no hyperacute rejection is to be expected. 10 This was a milestone for xenotransplantation in China, indicating that, following the United States, Japan, and Australia, Chinese scientists were one further step closer to the generation and breeding of pigs for xenotransplantation.
| The variety of genetically modified pigs
To date, the two major issues in xenotransplantation are (hyperacute) rejection and potential cross-species transmission of porcine endogenous retrovirus (PERV). To overcome these difficulties, Chinese scientists then turned to generating GTKO 11, 12 and PERV-free pigs. 13, 14 Chinese scientists have generated a variety of genetically modified pigs listed in Table 1 . Luhan Yang has distinguished herself by generating genomewide inactivation of PERV in pigs using the CRISPR/Cas9 technology ( Figure 3) . 13, 14, 19 This multinational team successfully inactivated all PERV sequences in a porcine primary cell line, representing a breakthrough in xenotransplantation. Dengke Pan, mentioned above, contributed substantially to the xenotransplantation field by generating several kinds of genetically modified pigs including the GGTA1-knockout pig using a combination of TALEN mRNA and magnetic beads with SCNT, 20, 21 GTKO/CD46 pigs, 22 and GGTA1/β4GalNT2/CMAH knockout pigs 22 by genetically deleting three major glycan antigens (see Table 1 for a complete list).
| PI G -TO -NONH UMAN PRIMATE XENOTR ANS PL ANTATION IN CHINA
| Liver and renal xenotransplantation
With the variety of genetically modified pigs, Chinese scientists moved forward to preclinical research in pig-to-nonhuman primateand pig-to-rat xenotransplantation models ( Table 2 , Figure 4A ). Dr Kefeng Dou, the first surgeon and scientist in
China to perform pig-to-nonhuman primate liver and kidney transplantation, and his team have completed 10 cases of pigto-Tibetan macaque auxiliary liver xenotransplantation and one case of kidney xenotransplantation. Transplanted organs were from GTKO minipigs generated by Dengke Pan, and recipients were Tibetan macaques, which have similar physiological and biochemical parameters to humans . 9 As expected, the pig liver functioned well by continuously secreting bile, and the xenograft survived for 2 weeks; this was considered a great success in xenotransplantation. The control was a monkey that received a wild-type pig liver, and this resulted in acute rejection already during the surgery. Moreover, 12 days after operation, computerized tomography angiography clearly showed no signs of coagulation disorder or thrombosis in the xenograft. 
| Cornea xenotransplantation
Zhiqiang Pan and his team transplanted full-thickness porcine corneal grafts from wild-type and GTKO/CD46 pigs into rhesus monkeys. Surprisingly, there was no statistically significant difference in graft survival between the wild-type and GTKO/ CD46 pig corneas, 157 and171 days, respectively. All xenograft recipients developed a retrocorneal membrane, with infiltration by CD3+ T cells at the corneal stroma, and manifested increased IL-6 expression six months after transplantation. 22 In order to prepare the porcine descemet membrane endothelial keratoplasty (DMEK) grafts, Zhiqiang Pan applied a mechanical stripping and liquid bubble technique, resulting in the conclusion that xeno-DMEK could be a promising approach for pig cornea transplantation. 24 This study also showed that there was no PERV transmission from Wuzhishan minipigs to rhesus monkey recipients. 25 Zuguo Liu also investigated the stability, physico-mechanical properties and biocompatibility of decellularized porcine corneal matrix, finding that this novel cornea material had good transparency, stability, and physico-mechanical properties. Also, the decellularized porcine corneal matrix was cytocompatible, so that this material has the potential for application in corneal tissue engineering. 26 In another study, Zuguo
Liu developed a novel lamellar corneal biomaterial for cornea reconstruction. Porcine acellular corneal stroma disks were obtained from de-epithelialized fresh porcine corneas; in the assessment of these stroma disks for biomechanical properties and histocompatibility in vivo and in vitro, these disks remained 
| Skin xenotransplantation
In clinical practice of wound care, pig skin is frequently used as a substitute for human skin. Studies by Liangxue Lai demonstrated that hCTLA4Ig-transgenic pigs suppress human lymphocyte proliferation in mixed lymphocyte cultures. Also, in pig-to-rat skin transplantation, hCTLA4Ig pig skin xenografts demonstrated remarkably prolonged survival compared to wild-type xenografts.
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( Figure 4B ).
| CLINIC AL XENOTR AN S PL ANTATI ON IN CHINA
| Islet xenotransplantation
Dr Wei Wang from Xiangya School of Medicine and Hunan
Xenograft Engineering Technology Research Center has focused on islet xenotransplantation from pigs to diabetic patients, for more than five years. Neonatal porcine islet cell clusters (NPICC)
were used in which the expression of tissue factor (TF) was reduced by TF-specific antisense RNA 30 or small interfering RNA (siRNA) approaches 31 ; as a result, the instant blood-mediated inflammatory reaction after implantation was suppressed. Also, NPICC were cultured in endothelial cell growth medium-2 to reduce the apoptosis of NPICC. 32 To improve the resistance to hypoxia, a combined culture of NPICC with human mesenchymal stem cell-derived exosomes was performed. 33 Between 2013 and 2017, Wei Wang and his team transplanted "newborn pig islets" into 10 patients with type 1 diabetes (http://en.xy3yy.com/document/show_12/184. html). The condition of these patients improved substantially, and the comprehensive score of transplantation was higher than that of a similar Japanese experiment.
| Cornea and decellularized heart valve xenotransplantation
In April 2015, the China Food and Drug Administration (CFDA) issued a medical device registration certificate for "Ai Xin Tong," a hallmark in the field of cornea regenerative medicine ( Figure 4C ). "Ai Xin Tong" is a bioengineered cornea (decellularized porcine corneal stroma) developed and patented by Chinese scientists. This is the first bioengineered cornea in the world that has completed clinical trials, a milestone in the field of ophthalmology. The application of "Ai Xin Tong" to human patients could solve the problem of cornea shortage in China, and bring hope for millions of patients waiting for corneal transplantation ( Figure 4C ).
Yifan Dai and his group performedheart valve replacement using bioprosthetic heart valves (BHVs) with material from GGTA1,
F I G U R E 3 Generation of PERV-free pigs by gene-editing technology CRISPR/Cas9
CMAH, and β-1,4-N-acetyl-galactosaminyl transferase 2 (β4GalNT2) triple gene-knockout (TKO) pigs. 34 The results showed minimal binding of human IgG/IgM to the pericardium. Also, based on the collagen composition and physical characteristics of porcine pericardium, the elimination of the three xenoantigens by genetic modification had no relevant impact on the physical proprieties of porcine pericardium: This further demonstrated that genetically modified pigs could be an ideal source of BHVs in heart valve replacement. 
TA B L E 2 Pig-to-nonhuman primate or human transplantation in China
| CON CLUS I ON S AND PER S PEC TIVE S
With the implementation of gene editing including CRISPR/ Cas9, TALEN and SCNT in genetic modification of potential pig donors for transplantation, great progress has been made in the xenotransplantation field. Chinese scientists have generated various genetically modified pig strains, such as PERVfree pigs and GTKO pigs. Therefore, pig liver, kidney, islet, heart valve, and cornea have been extensively used in advanced preclinical and initial clinical studies. Although at present xenotransplantation is limited to small groups of studies, we expect that it will gradually evolve into clinical practice.
With increasing numbers of suitable organs from genetically modified pigs produced in China, China has the potential to become a world-renowned pig organ center, with the perspective of minimizing or even eliminating the current organ shortage for transplantation.
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